# Baxalta Belgium Manufacturing SA - Inspection Records

Source: https://www.keypedia.com/companies/baxalta-belgium-manufacturing-sa/61b3acce-a147-4f22-b13a-34bb436ea8e9

> Inspection records and compliance data for Baxalta Belgium Manufacturing SA in Lessines, None. Access full analysis and detailed observations.

---

## Details

- Name: Baxalta Belgium Manufacturing SA
- FEI Number: 3002806503
- City: Lessines
- State: None
- Country Name: Belgium
- Address Line 1: Boulevard Rene Branquart 80
- Zip Code: None

## Related Documents

- [483 - Baxalta Belgium Manufacturing SA - 2024-11-22](https://www.keypedia.com/records/483/baxalta-belgium-manufacturing-sa/675a7f46-8637-422d-834e-98f80bbc5db6) — source: FDA, date: November 22, 2024
- [483 - Baxalta Belgium Manufacturing SA - 2024-11-22](https://www.keypedia.com/records/483/baxalta-belgium-manufacturing-sa/d58d9b78-e7e5-42a0-b2c8-6d8a4357eb4f) — source: FDA, date: November 22, 2024
- [483 - Baxalta Belgium Manufacturing SA - 2024-11-22](https://www.keypedia.com/records/483/baxalta-belgium-manufacturing-sa/6605c825-fc8a-48a9-adec-e289950a147a) — source: FDA, date: November 22, 2024
- [FDA Inspection 1251969 - Baxalta Belgium Manufacturing SA - 2024-11-22](https://www.keypedia.com/records/fda_inspections/baxalta-belgium-manufacturing-sa/115e13ec-e43f-4a5d-a6ea-a44fb33f7402) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 22, 2024
- [FDA Inspection 1093550 - Baxalta Belgium Manufacturing SA - 2019-05-31](https://www.keypedia.com/records/fda_inspections/baxalta-belgium-manufacturing-sa/cd4ac129-b584-44b0-be5e-b240449bbf4c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 31, 2019
- [483 - Baxalta Belgium Manufacturing SA - 2019-05-20](https://www.keypedia.com/records/483/baxalta-belgium-manufacturing-sa/6dbcde81-2291-4b42-a556-6dc3897f5b55) — source: FDA, date: May 20, 2019
- [FDA Inspection 918229 - Baxalta Belgium Manufacturing SA - 2015-02-24](https://www.keypedia.com/records/fda_inspections/baxalta-belgium-manufacturing-sa/517a0fe7-a773-4b40-a359-fba5e341e1c6) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 24, 2015
- [FDA Inspection 918229 - Baxalta Belgium Manufacturing SA - 2015-02-24](https://www.keypedia.com/records/fda_inspections/baxalta-belgium-manufacturing-sa/c3d349dd-96b7-4ba0-8825-6438659630b9) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 24, 2015
- [FDA Inspection 841219 - Baxalta Belgium Manufacturing SA - 2013-06-18](https://www.keypedia.com/records/fda_inspections/baxalta-belgium-manufacturing-sa/23cdccd0-46d0-4c57-a5a1-f0ad4715baa9) — classification: No Action Indicated (NAI), source: FDA, date: June 18, 2013
- [FDA Inspection 841219 - Baxalta Belgium Manufacturing SA - 2013-06-18](https://www.keypedia.com/records/fda_inspections/baxalta-belgium-manufacturing-sa/1390dc0d-f01d-499b-ba27-14aca059294b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 18, 2013
- [FDA Inspection 827427 - Baxalta Belgium Manufacturing SA - 2013-03-19](https://www.keypedia.com/records/fda_inspections/baxalta-belgium-manufacturing-sa/28869407-e513-4cb0-99b7-af0914802c7a) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 19, 2013
- [FDA Inspection 712920 - Baxalta Belgium Manufacturing SA - 2011-01-21](https://www.keypedia.com/records/fda_inspections/baxalta-belgium-manufacturing-sa/57ba0239-ccad-4fd3-bc2b-413d013423bb) — classification: Official Action Indicated (OAI), source: FDA, date: January 21, 2011
- [FDA Inspection 622355 - Baxalta Belgium Manufacturing SA - 2009-10-19](https://www.keypedia.com/records/fda_inspections/baxalta-belgium-manufacturing-sa/0e1f4568-500c-413f-9bb0-12e8e9853325) — classification: Official Action Indicated (OAI), source: FDA, date: October 19, 2009

## Related Companies

- [Nordmark Arzneimittel GMBH & Co. KG](https://www.keypedia.com/companies/nordmark-arzneimittel-gmbh-co-kg/871eb270-8517-4646-923a-b4d2eb0ea73b)
- [Eli Lilly & Company](https://www.keypedia.com/companies/eli-lilly-company/fc56eed7-d261-4de3-865e-c2aa54162adf)
- [FUJIFILM Diosynth Biotechnologies Denmark ApS](https://www.keypedia.com/companies/fujifilm-diosynth-biotechnologies-denmark-aps/513b3c42-1517-43bc-936a-d3edd26bed70)
- [Patheon Pharmaceuticals Inc.](https://www.keypedia.com/companies/patheon-pharmaceuticals-inc/f1ef6b53-3c20-4c22-9ef3-fd05fdb9f35b)
- [Novartis Pharma Stein AG](https://www.keypedia.com/companies/novartis-pharma-stein-ag/06be1f01-8421-471e-9d38-475fef9a9c5b)
- [Ferring Microbiome Inc.](https://www.keypedia.com/companies/ferring-microbiome-inc/860d4130-d93a-4017-97ca-30033280de85)
- [Latina Pharma S.p.A.](https://www.keypedia.com/companies/latina-pharma-spa/9cb7e758-39a0-4b4c-bfad-93d1468f5d38)
- [Amgen Manufacturing Ltd](https://www.keypedia.com/companies/amgen-manufacturing-ltd/cecb788c-4cd6-4c26-9331-7b68b4f12369)
- [Biological E. Limited](https://www.keypedia.com/companies/biological-e-limited/a02640a2-3dc0-448e-9a4f-df7e189939e4)
- [Hospira Zagreb d.o.o.](https://www.keypedia.com/companies/hospira-zagreb-doo/7c1e84f8-a21e-4e90-896a-ac33304219f1)

## Related Officers

- [Mizraim E. Lewis](https://www.keypedia.com/people/mizraim-e-lewis/ab13c6e2-d94d-4438-b9b8-9537acd58ccc)
- [investigator](https://www.keypedia.com/people/yonggang-wang/5c7dd00f-f810-4f86-9c78-51ae7f4b8acd)
- [Alan L. Truong](https://www.keypedia.com/people/alan-l-truong/8b9c59ed-ce68-44c3-9fbe-07cc3da13713)
- [issuing_officer](https://www.keypedia.com/people/malgorzata-g-norton/ba7b8827-0976-4abd-8abb-95d4222d2bdc)
- [Investigator](https://www.keypedia.com/people/shafiq-s-ahadi/dd146b0a-ca1c-4052-8f50-4d68e14ad73f)